|
Market Closed -
Nasdaq
00:00:00 14/11/2026 +03
|
5-day change | 1st Jan Change | ||
| 241.55 USD | +0.49% |
|
+2.89% | +42.09% |
| 11-03 | RBC Raises Price Target on Jazz Pharmaceuticals to $305 From $296, Keeps Outperform Rating | MT |
| 11-03 | Jazz Pharmaceuticals plc, Q3 2026 Earnings Call, Nov 02, 2026 |
| Market Cap | 15.43B 13.98B 12.93B 11.67B 21.99B 1,455B 22.76B 155B 61.6B 777B 57.9B 56.67B 2,467B | P/E 2026 * |
60.7x | P/E 2027 * | 14.6x |
|---|---|---|---|---|---|
| Enterprise Value | 18.18B 16.48B 15.24B 13.75B 25.91B 1,714B 26.82B 183B 72.59B 916B 68.23B 66.78B 2,907B | EV / Sales 2026 * |
3.78x | EV / Sales 2027 * | 3.24x |
| Free-Float |
96.78% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| JAZZ | Delayed | |
CBOE
| JAZZ | Real-time | |
|
Tradegate
| J7Z | Real-time | |
|
Börse Stuttgart
| J7Z | Delayed | |
|
Boerse Muenchen
| J7Z | Real-time | |
|
Deutsche Boerse AG
| J7Z | Delayed | |
|
Berne S.E.
| J7Z | End-of-day quote | |
|
Borsa Italiana
| 1JAZZ | End-of-day quote | |
|
Xetra
| J7Z | Delayed |
Last Transcript: Jazz Pharmaceuticals plc
| 1 day | +0.49% | ||
| 1 week | +6.26% | ||
| Current month | +11.84% | ||
| 1 month | +11.44% | ||
| 3 months | -2.97% | ||
| 6 months | +6.02% | ||
| Current year | +42.09% |
| 1 week | 235.14 |  | 249.99 |
| 1 month | 202.3 | | 249.99 |
| Current year | 156.95 | | 266.38 |
| 1 year | 139.26 | | 266.38 |
| 3 years | 95.49 | | 266.38 |
| 5 years | 95.49 | | 266.38 |
| 10 years | 86.88 | | 266.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
Renée Galá
CEO | Chief Executive Officer | 54 | 11/08/2025 |
Philip Johnson
DFI | Director of Finance/CFO | 62 | 01/03/2024 |
Mary Henderson
CTO | Chief Tech/Sci/R&D Officer | 54 | 01/08/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Bruce Cozadd
CHM | Chairman | 62 | 01/03/2003 |
Seamus Mulligan
BRD | Director/Board Member | 65 | 18/01/2012 |
Rick Winningham
BRD | Director/Board Member | 66 | 01/01/2010 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 11/3/26 A | Sell | Chief Executive Officer | -1,000 | 0.0015% | ||
| 11/2/26 A | Sell | Founder | -6,000 | 0.0092% | ||
| 10/6/26 A | Sell | Chief Executive Officer | -2,000 | 0.0031% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +6.26% | +76.69% | +100.96% | 15.43B | |
| +1.26% | +5.77% | +41.83% | +141.51% | 1,271B | |
| +0.79% | +4.93% | +47.00% | +94.06% | 683B | |
| +0.20% | +2.36% | +26.50% | +112.88% | 520B | |
| -0.44% | +3.32% | +39.36% | +70.94% | 389B | |
| +0.55% | +0.56% | +61.57% | +45.73% | 362B | |
| -0.12% | -0.04% | +28.04% | +59.86% | 304B | |
| +0.37% | -0.43% | +3.43% | +38.57% | 286B | |
| -0.30% | +1.17% | +38.48% | +74.21% | 253B | |
| +0.08% | +0.30% | +36.21% | +121.39% | 208B | |
| Average | +0.29% | +2.13% | +39.91% | +86.01% | 429B | |
| Weighted average by Cap. | +0.53% | +2.68% | +38.36% | +98.29% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 4.8B 4.35B 4.03B 3.63B 6.85B 453B 7.09B 48.38B 19.18B 242B 18.03B 17.65B 768B | 5.06B 4.58B 4.24B 3.83B 7.21B 477B 7.46B 50.94B 20.2B 255B 18.98B 18.58B 809B |
| Net income | 286M 259M 240M 216M 408M 26.99B 422M 2.88B 1.14B 14.42B 1.07B 1.05B 45.77B | 1.13B 1.02B 947M 855M 1.61B 107B 1.67B 11.38B 4.51B 56.92B 4.24B 4.15B 181B |
| Net Debt | 2.75B 2.49B 2.31B 2.08B 3.92B 259B 4.06B 27.71B 10.99B 139B 10.33B 10.11B 440B | 975M 884M 817M 737M 1.39B 91.93B 1.44B 9.82B 3.89B 49.11B 3.66B 3.58B 156B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 13/11/26 | $241.55 | +0.49% | 496,700 |
| 12/11/26 | $240.37 | -3.17% | 584,415 |
| 11/11/26 | $248.24 | +1.14% | 592,854 |
| 10/11/26 | $245.43 | +0.77% | 576,714 |
| 09/11/26 | $243.55 | +3.74% | 886,048 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
- Stock Market
- Stocks
- JAZZ Stock
Select your edition
All financial news and data tailored to specific country editions
